Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SNNA

Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis

Sienna Biopharmaceuticals logo

About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)

Advanced Chart

Key Stats

Today's Range
$0.11
$0.17
50-Day Range
$0.14
$0.14
52-Week Range
$0.06
$3.80
Volume
13.32 million shs
Average Volume
1.87 million shs
Market Capitalization
$4.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNNA Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Sienna Ross: Live In Fort Worth
See More Headlines

SNNA Stock Analysis - Frequently Asked Questions

Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.93) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10.

Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Protalix BioTherapeutics (PLX), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Motif Bio (MTFB) and Ritter Pharmaceuticals (RTTR).

Company Calendar

Last Earnings
3/14/2019
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNNA
CIK
1656328
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$73.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-177.36%
Return on Assets
-52.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.27
Quick Ratio
15.27

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.27 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
30,908,000
Free Float
N/A
Market Cap
$4.20 million
Optionable
Not Optionable
Beta
2.67
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:SNNA) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners